Our previously published data demonstrated that depletion of ATP-citrate-lyase (ACL) repressed A549 lung cancer cell proliferation in vitro and growth in vivo, and that this was accompanied by citrate accumulation, suggesting a potential antitumor function for citrate6. The gene discussed is ACLY; the disease is lung cancer.